Literature DB >> 22469506

The genetics of gestational trophoblastic disease: a rare complication of pregnancy.

Lori Hoffner1, Urvashi Surti.   

Abstract

Gestational choriocarcinoma is usually a rapidly spreading fatal disease, but it is curable if diagnosed early and treated. It is a unique malignancy that is a partial or complete allograft with a genotype that is not the same as the host genotype. It is most often preceded by an abnormal molar pregnancy. The surprising and unique androgenetic origin of complete hydatidiform molar pregnancies was first revealed by Kajii and Ohama in 1977. We describe the current understanding of the morphology, epidemiology and genetics of gestational trophoblastic disease that followed the milestone findings by Kajii and Ohama.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469506     DOI: 10.1016/j.cancergen.2012.01.004

Source DB:  PubMed          Journal:  Cancer Genet


  24 in total

Review 1.  Molecular genetic studies of complete hydatidiform moles.

Authors:  Louise Carey; Benjamin M Nash; Dale C Wright
Journal:  Transl Pediatr       Date:  2015-04

2.  Hydatidiform molar pregnancy following assisted reproduction.

Authors:  M Nickkho-Amiry; G Horne; M Akhtar; R Mathur; D R Brison
Journal:  J Assist Reprod Genet       Date:  2019-01-05       Impact factor: 3.412

3.  A pilot study comparing the genetic molecular biology of gestational and non-gestational choriocarcinoma.

Authors:  Cordelle Lazare; Wenhua Zhi; Jun Dai; Canhui Cao; Rajiv Rai Sookha; Ling Wang; Yifan Meng; Peipei Gao; Ping Wu; Juncheng Wei; Junbo Hu; Peng Wu
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

4.  Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015).

Authors:  C Tempfer; L-C Horn; S Ackermann; M W Beckmann; R Dittrich; J Einenkel; A Günthert; H Haase; J Kratzsch; M C Kreissl; S Polterauer; A D Ebert; K T M Schneider; H G Strauss; F Thiel
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

5.  Intracranial choriocarcinoma occurrence in males: Two cases and a review of the literature.

Authors:  Jianyi Guo; Chunlong Zhong; Qiang Liu; Jiwen Xu; Yan Zheng; Siyi Xu; Yang Gao; Yang Guo; Yong Wang; Qizhong Luo; Jiyao Jiang
Journal:  Oncol Lett       Date:  2013-09-09       Impact factor: 2.967

6.  Single haplotype assembly of the human genome from a hydatidiform mole.

Authors:  Karyn Meltz Steinberg; Valerie A Schneider; Tina A Graves-Lindsay; Robert S Fulton; Richa Agarwala; John Huddleston; Sergey A Shiryev; Aleksandr Morgulis; Urvashi Surti; Wesley C Warren; Deanna M Church; Evan E Eichler; Richard K Wilson
Journal:  Genome Res       Date:  2014-11-04       Impact factor: 9.043

7.  MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.

Authors:  Ronald Tk Pang; Carmen On Leung; Cheuk-Lun Lee; Kevin Kw Lam; Tian-Min Ye; Philip Cn Chiu; William Sb Yeung
Journal:  BMC Cancer       Date:  2013-01-18       Impact factor: 4.430

8.  Triploidy--Observations in 154 Diandric Cases.

Authors:  Nanna Brink Scholz; Lars Bolund; Mette Nyegaard; Louise Faaborg; Mette Warming Jørgensen; Helle Lund; Isa Niemann; Lone Sunde
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

Review 9.  'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic era.

Authors:  Gkikas Magiorkinis; Robert Belshaw; Aris Katzourakis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-08-12       Impact factor: 6.237

10.  Absence of Maternal Methylation in Biparental Hydatidiform Moles from Women with NLRP7 Maternal-Effect Mutations Reveals Widespread Placenta-Specific Imprinting.

Authors:  Marta Sanchez-Delgado; Alejandro Martin-Trujillo; Chiharu Tayama; Enrique Vidal; Manel Esteller; Isabel Iglesias-Platas; Nandita Deo; Olivia Barney; Ken Maclean; Kenichiro Hata; Kazuhiko Nakabayashi; Rosemary Fisher; David Monk
Journal:  PLoS Genet       Date:  2015-11-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.